|
|
News Breaks | | | | January 17, 2013 | | 16:09 EDT |  | INO | Inovio Pharma initiated with an Overweight at Piper Jaffray
Target $1. | |
|
News For INO From The Last 14 Days Check below for free stories on INO the last two weeks. |
|
|
| May 14, 2013 | | 09:18 EDT |  | INO | Inovio announces positive results from preclinical study of SynCon DNA vaccine
Inovio announced that in a preclinical study of Inovio's SynCon DNA vaccine against Ebola and Marburg filoviruses, labeled "Category A" bioterrorism agents by the U.S. government, the vaccine induced strong and broad immune responses and demonstrated 100% protection against death following a challenge with multiple variants of the pathogen in two animal models. | | | May 10, 2013 | | 16:42 EDT |  | INO | Inovio reports Q1 EPS (6c), consensus (4c)
 Subscribe for More Information | |
|
|
|
|
|
|
